Pregabalin is structurally similar to gamma-aminobutyric acid (GABA) - an inhibitory neurotransmitter. It may be used to manage neuropathic pain, postherpetic neuralgia, and fibromyalgia among other conditions. Although as per the FDA Label the mechanism of action has not been definitively defined, there is evidence that pregabalin exerts its effects by bind...
Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.
Women's Options Center, Honolulu, Hawaii, United States
Anat Galor, Miami, Florida, United States
Kyungpook National University Hospital, Daegu, Korea, Republic of
Kyungpook National University Hospital, Daegu, Korea, Republic of
Johns Hopkins Hospital, Baltimore, Maryland, United States
The Ottawa Hospital (General and Civic Campuses), Ottawa, Ontario, Canada
Turku University Hospital, Turku, Finland
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.